Literature DB >> 15592189

Comparison between Tc-99m N-NOET and Tl-201 in the assessment of patients with known or suspected coronary artery disease.

Paramjit Jeetley1, Nikant K Sabharwal, Prem Soman, Chris Kinsey, Usha Raval, Uday Bhonsle, Avijit Lahiri.   

Abstract

BACKGROUND: Technetium 99m N-ethoxy-N-ethyl dithiocarbamate (N-NOET) is a new radionuclide tracer for cardiac single photon emission computed tomography (SPECT) imaging. It combines the advantageous properties of a Tc-99m agent with the redistribution characteristics of thallium 201. We directly compared the two agents in patients with known or suspected coronary artery disease. METHODS AND
RESULTS: Fifty patients underwent treadmill exercise Tc-99m N-NOET and Tl-201 SPECT studies. Images were acquired at stress, redistribution, and reinjection. Segmental analysis was carried out, and direct comparisons were made with corresponding segments. A stress score index was calculated and compared with the degree of lung uptake for each patient. From the 50 patients, 2657 of 2664 exercise, redistribution, and reinjection segments (99%) were interpreted. There was excellent agreement between the two modalities (weighted kappa = 0.83). Of the patients, 24 demonstrated reversible ischemia by Tl-201 SPECT reinjection imaging, of which Tc-99m N-NOET stress-redistribution imaging correctly identified 14 (58%); this improved significantly to 20 patients (83%) ( P = .03) when a reinjection protocol was used. A higher stress score index was seen in those patients with significant lung uptake (lung-heart ratio > or =0.6) after Tc-99m N-NOET stress imaging (1.6 vs 1.3, P = .03).
CONCLUSION: SPECT imaging with Tc-99m N-NOET is comparable to Tl-201 for the diagnosis of coronary artery disease. Significant lung uptake with stress Tc-99m N-NOET may also indicate the severity of disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15592189     DOI: 10.1016/j.nuclcard.2004.05.010

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  19 in total

1.  Biodistribution, dosimetry, and safety of myocardial perfusion imaging agent 99mTcN-NOET in healthy volunteers.

Authors:  G Vanzetto; D Fagret; R Pasqualini; J P Mathieu; F Chossat; J Machecourt
Journal:  J Nucl Med       Date:  2000-01       Impact factor: 10.057

2.  99mTc-N-NOET imaging for myocardial perfusion: can it offer more than we already have?

Authors:  D Fagret; C Ghezzi; G Vanzetto
Journal:  J Nucl Med       Date:  2001-09       Impact factor: 10.057

3.  Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease.

Authors:  H Shanoudy; P Raggi; G A Beller; A Soliman; E G Ammermann; R J Kastner; D D Watson
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

4.  Comparison of pulmonary uptake with transient cavity dilation after dipyridamole Tl-201 perfusion imaging.

Authors:  Christopher L Hansen; Puxiao Cen; Benjamin Sanchez; Reginald Robinson
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

5.  Quantitative aspects of myocardial perfusion imaging.

Authors:  S Kaul; D A Chesler; C A Boucher; R D Okada
Journal:  Semin Nucl Med       Date:  1987-04       Impact factor: 4.446

6.  Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease.

Authors:  P Soman; R Taillefer; E G DePuey; J E Udelson; A Lahiri
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

7.  The effect of ischemic injury on the cardiac transport of Tc-99m N-NOET in the isolated rabbit heart.

Authors:  T A Holly; J A Leppo; M P Gilmore; C P Reinhardt; S T Dahlberg
Journal:  J Nucl Cardiol       Date:  1999 Nov-Dec       Impact factor: 5.952

8.  Technetium 99m-labeled sestamibi imaging reliably identifies retained contractile reserve in dyssynergic myocardial segments.

Authors:  R Senior; U Raval; A Lahiri
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

9.  Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging.

Authors:  V Dilsizian; T P Rocco; N M Freedman; M B Leon; R O Bonow
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

10.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.

Authors:  F J Wackers; D S Berman; J Maddahi; D D Watson; G A Beller; H W Strauss; C A Boucher; M Picard; B L Holman; R Fridrich
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

View more
  3 in total

1.  Tc-99m N-NOET: Chronicle of a unique perfusion imaging agent and a missed opportunity?

Authors:  Gérald Vanzetto; Daniel Fagret; Catherine Ghezzi
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

Review 2.  Dithiocarbamate complexes as radiopharmaceuticals for medical imaging.

Authors:  David J Berry; Rafael Torres Martin de Rosales; Putthiporn Charoenphun; Philip J Blower
Journal:  Mini Rev Med Chem       Date:  2012-10       Impact factor: 3.862

3.  The in vivo cardiac kinetics of Tc-99m N-NOET are accelerated in obese, hyperlipidemic Zucker rats.

Authors:  Laurent M Riou; Alexis Broisat; Julien Dimastromatteo; Gérald Vanzetto; Daniel Fagret; Catherine Ghezzi
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.